Basic Information
LncRNA/CircRNA Name | circ_0132266 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | chronic lymphocytic leukemia |
ICD-0-3 | NA |
Methods | qRT-PCR , Dual luciferase reporter assay , western blot , RIP , CCK8 assay , cell apoptosis assay , IF and FISH |
Sample | cell lines(MEC-1 ,HEK-293T) |
Expression Pattern | down-regulated |
Function Description | Here, we observed hsa_circ_0132266 (circ_0132266), a circRNA significantly decreased in the peripheral blood mononuclear cells (PBMCs) of CLL patients compared with healthy donors, could act as an endogenous sponge of hsa-miR-337-3p (miR-337-3p) and regulate its activity, which resulted in a downstream change of target-gene PML and a consequent influence on cell viability. |
Pubmed ID | 31152142 |
Year | 2019 |
Title | Downregulation of circ_0132266 in Chronic Lymphocytic Leukemia Promoted Cell Viability Through miR-337-3p/PML Axis |
External Links
Links for circ_0132266 | GenBank HGNC NONCODE |
Links for chronic lymphocytic leukemia | OMIM COSMIC |